Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Detection of Glioma Treatment Response Using MRI-Based Biomarkers

NCT01996527 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.

NCT NCT01996527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01996527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Detection of Glioma Treatment Response Using MRI-Based Biomarkers
Lead sponsor
Vanderbilt-Ingram Cancer Center
Phase
Phase 1
Overall status
Terminated
Start date
May 31, 2012
Completion date
January 1, 2016
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult anaplastic astrocytoma, adult anaplastic ependymoma, adult anaplastic oligodendroglioma, adult giant cell glioblastoma, adult glioblastoma, adult gliosarcoma, recurrent adult brain tumor